๐
Vijoice
alpelisib
Genetic Diseases, Inborn;Growth Disorders
๐ซ Withdrawn
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Treatment of patients with severe manifestations of PIK3CA-related overgrowth spectrum
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/vijoice-w